{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:12:07Z","timestamp":1780326727148,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.ejpn.2013.03.002","type":"journal-article","created":{"date-parts":[[2013,4,6]],"date-time":"2013-04-06T05:46:33Z","timestamp":1365227193000},"page":"479-485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex"],"prefix":"10.1016","volume":"17","author":[{"given":"Katarzyna","family":"Kotulska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Chmielewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julita","family":"Borkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Jurkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Kuczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Kmie\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"\u0141ojszczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Dunin-W\u0105sowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiusz","family":"J\u00f3\u017awiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2013.03.002_bib1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejpn.2013.03.002_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-4632.2010.04727.x","article-title":"Tuberous sclerosis complex: tumors and tumorigenesis","volume":"50","author":"Borkowska","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ejpn.2013.03.002_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/hmg\/ddi260","article-title":"Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways","volume":"14","author":"Kwiatkowski","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ejpn.2013.03.002_bib4","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/jnen\/63.12.1236","article-title":"Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation","volume":"63","author":"Chan","year":"2004","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.ejpn.2013.03.002_bib5","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.2353\/ajpath.2010.090950","article-title":"Novel proteins regulated by mTOR in subependymal giant cell astrocytomas of patients with tuberous sclerosis complex and new therapeutic implications","volume":"176","author":"Tyburczy","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejpn.2013.03.002_bib6","first-page":"139","article-title":"Brain lesions in tuberous sclerosis complex","volume":"48","author":"Grajkowska","year":"2010","journal-title":"Review Folia Neuropathol"},{"key":"10.1016\/j.ejpn.2013.03.002_bib7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1468-1331.2009.02567.x","article-title":"Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature","volume":"16","author":"Adriaensen","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ejpn.2013.03.002_bib8","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0025-6196(12)61196-3","article-title":"Causes of death in patients with tuberous sclerosis","volume":"66","author":"Shepherd","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ejpn.2013.03.002_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1010664311717","article-title":"Biological behavior and tumorigenesis of subependymal giant cell astrocytomas","volume":"52","author":"Kim","year":"2001","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.ejpn.2013.03.002_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1227\/01.NEU.0000249216.19591.5D","article-title":"Subependymal giant-cell astrocytomas in pediatric tuberous sclerosis disease: when should we operate?","volume":"60","author":"de Ribaupierre","year":"2007","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ejpn.2013.03.002_bib11","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1528-1167.2007.01035.x","article-title":"Tuberous sclerosis complex and epilepsy: recent developments and future challenges","volume":"48","author":"Holmes","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2013.03.002_bib12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archneur.55.3.379","article-title":"Poor mental development in patients with tuberous sclerosis complex: clinical risk factors","volume":"55","author":"J\u00f3\u017awiak","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ejpn.2013.03.002_bib13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejpn.2011.03.010","article-title":"Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex","volume":"15","author":"J\u00f3\u017awiak","year":"2011","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.ejpn.2013.03.002_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1528-1167.2009.02341.x","article-title":"Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies","volume":"51","author":"Wong","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2013.03.002_bib15","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1111\/j.1528-1167.2007.01178_3.x","article-title":"Treatment before seizures: new indications for antiepileptic therapy in children with tuberous sclerosis complex","volume":"48","author":"J\u00f3zwiak","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2013.03.002_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejpn.2011.09.006","article-title":"Effective everolimus treatment of inoperable, life-threatening subependymal giant cell astrocytoma and intractable epilepsy in a patient with tuberous sclerosis complex","volume":"16","author":"Perek-Polnik","year":"2011","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.ejpn.2013.03.002_bib17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/0883073808324535","article-title":"Rapamycin reduces seizure frequency in tuberous sclerosis complex","volume":"24","author":"Muncy","year":"2009","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ejpn.2013.03.002_bib18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrclinonc.2010.21","article-title":"mTOR signaling and drug development in cancer","volume":"7","author":"Dancey","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejpn.2013.03.002_bib19","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1399-3046.2011.01515.x","article-title":"The use of everolimus in pediatric liver transplants recipients: first experience in a single center","volume":"15","author":"Nielsen","year":"2011","journal-title":"Pediatr Transplant."},{"key":"10.1016\/j.ejpn.2013.03.002_bib20","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1111\/j.1600-6143.2010.03266.x","article-title":"De novo therapy with everolimus, low dose ciclosporine A, basiliximab and steroid elimination in pediatric kidney transplantation","volume":"10","author":"Pape","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ejpn.2013.03.002_bib21","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejpn.2013.03.002_bib22","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.ejca.2011.03.017","article-title":"Natural history, management and pharmacokinetics of everolimus-induced oral ulcers: insights into compliance issues","volume":"47","author":"Ferte","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejpn.2013.03.002_bib23","article-title":"Efficacy and safety of everolimus for the treatment of subependymal giant-cell astrocytomas associated with tuberous sclerosis complex: a multicentre, randomized, placebo-controlled trial","author":"Franz","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejpn.2013.03.002_bib24","first-page":"95","article-title":"Assessment of physical development of children and adolescents. Part I. Infants and children up to 5 years \u2013 national reference values or WHO standards?","volume":"14","author":"Oblaci\u0144ska","year":"2010","journal-title":"Med Wieku Rozwoj"},{"key":"10.1016\/j.ejpn.2013.03.002_bib25","unstructured":"The Cancer Therapy Evaluation Program Common Terminology Criteria for Adverse Events, versions 3.0 http:\/\/ctep.cancer.gov\/forms."},{"key":"10.1016\/j.ejpn.2013.03.002_bib26","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","volume":"59","author":"Franz","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ejpn.2013.03.002_bib27","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/pbc.22298","article-title":"Rapamycin (sirolimus) in tuberous sclerosis associated pediatric central nervous system tumors","volume":"54","author":"Lam","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ejpn.2013.03.002_bib28","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1200\/JCO.2007.11.4017","article-title":"Phase I study of everolimus in pediatric patients with refractory solid tumors","volume":"25","author":"Fouladi","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejpn.2013.03.002_bib29","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00467-011-1811-3","article-title":"Growth of kidney-transplanted pediatric patients treated with sirolimus","volume":"26","author":"Gonzalez","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ejpn.2013.03.002_bib30","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1007\/s00467-009-1215-9","article-title":"Growth failure associated with sirolimus: case report","volume":"24","author":"Rangel","year":"2009","journal-title":"Pediatr Nephrol"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379813000287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379813000287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,17]],"date-time":"2018-10-17T00:02:36Z","timestamp":1539734556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379813000287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1090379813000287"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2013.03.002","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2013.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}